First Capital Ventures

B-Secur Ltd. is a Belfast-based company specializing in ECG biometric software that enhances digital security by utilizing unique heartbeat patterns for user identification. Founded in 1996, B-Secur has invested over 15 years in research and development, establishing itself as a leader in ECG technology. Their flagship product, HeartKey®, offers advanced physiological monitoring while ensuring data protection. The company has created a comprehensive suite of ECG algorithms and analytics that facilitate not only user authentication but also wellness and health monitoring. B-Secur collaborates with leading technology firms to integrate its innovative solutions into various devices and systems, providing significant advantages in development costs and design. With a robust foundation in hardware and material science, B-Secur is poised to transform the user experience in the connected world through secure and efficient biometric technology.

KromaTiD, Inc. is an early-stage bioscience company based in Fort Collins, Colorado, specializing in chromosome analysis for biomedical research and medical testing. Incorporated in 2007, the company develops advanced molecular cytogenetics assays and reagents that focus on detecting genetic abnormalities, including inversions and translocations. Utilizing its proprietary Directional Genomic Hybridization (dGH) technology, KromaTiD offers a range of products, including chromosome imaging tools, assays for targeting entire chromosomes or individual chromatids, and inversion detection solutions. Its dGH assays generate critical sequence, location, and orientation data from single cells, making them suitable for studies involving mixed cell populations. KromaTiD's innovations aim to enhance the understanding of genetic diseases, facilitating the development of novel therapeutics in oncology and rare diseases.